Patents-Review.com
πŸ”— Permalink
Assignee profile:

SANDOZ AG

City:

Basel

Country:

Switzerland

Published Applications:

208

Last publication date:

2025-10-23

Patent Grants:

144

Last grant date:

2026-03-31

Quarterly SANDOZ AG Patent Applications

Top Inventors for applications by SANDOZ AG

These are the the leading inventors for applications assigned to SANDOZ AG:

Recent patent applications by SANDOZ AG

SANDOZ AG based in Basel, CH has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2025-10-23
US20250325759A1
Human necessities

INHALER DEVICE

 #2 | 2024-12-19
US20240417417A1
Chemistry; metallurgy

Process for the preparation of sucrose octasulfate octakistriethylammonium salt (TASOS) powder and uses thereof

 #3 | 2024-10-17
US20240343712A1
Chemistry; metallurgy

SOLID-STATE FORMS OF 2-(3-(4-(1H-INDAZOL-5-YLAMINO)QUINAZOLIN-2-YL)PHENOXY)-N-ISOPROPYLACETAMIDE METHANE SULFONIC ACID SALT

 #4 | 2024-10-03
US20240327379A1
Chemistry; metallurgy

MANDELATE FORM OF 1-(4-(((6-AMINO-5-(4-PHENOXYPHENYL)PYRIMIDIN-4-YL)AMINO)METHYL)PIPERIDIN-1-YL)PROP-2-EN-1-ONE

 #5 | 2024-08-29
US20240287066A1
Chemistry; metallurgy

Crystalline Form of Sotorasib

 #6 | 2023-10-05
US20230310468A1
Human necessities

Parenteral pharmaceutical composition comprising cyclophosphamide and a mixture of liquids

 #7 | 2022-08-25 βœ… Patent 12,590,095 granted on 2026-03-31
US20220267334A1
Chemistry; metallurgy

CRYSTALLINE FORMS OF AN ORALLY AVAILABLE, SELECTIVE KIT AND PDGFR KINASE INHIBITOR

 #8 | 2022-03-31
US20220096507A1
Human necessities

Parenteral Pharmaceutical Composition Comprising Azacitidine or Decitabine in DMSO

 #9 | 2022-03-15 βœ… Patent 11,273,128 granted on 2022-03-15
US17231118
Human necessities

Elagolix formulation

 #10 | 2022-01-27 βœ… Patent 11,970,450 granted on 2024-04-30
US20220024874A1
Chemistry; metallurgy

Multi-component crystals of an orally available HIF prolyl hydroxylase inhibitor

 #11 | 2021-12-23 βœ… Patent 12,043,590 granted on 2024-07-23
US20210395186A1
Chemistry; metallurgy

Co-crystals comprising levothyroxine and a dicarboxylic acid

 #12 | 2021-12-16 βœ… Patent 12,453,826 granted on 2025-10-28
US20210386945A1
Human necessities

AN INHALER DEVICE

 #13 | 2021-09-30 βœ… Patent 11,479,798 granted on 2022-10-25
US20210301313A1
Chemistry; metallurgy

Recombinant host cell with altered membrane lipid composition

 #14 | 2021-09-30 βœ… Patent 11,897,897 granted on 2024-02-13
US20210300945A1
Chemistry; metallurgy

Crystalline forms of cabotegravir sodium

 #15 | 2021-09-23
US20210290550A1
Human necessities

Process for Preparing Rapidly or Very Rapidly Dissolving Tablets Comprising Freely Soluble API

 #16 | 2021-08-19
US20210253521A1
Chemistry; metallurgy

Crystalline Eravacycline Bis-Hydrochloride

 #17 | 2021-07-08
US20210206770A1
Chemistry; metallurgy

Co-Crystal of an Orally Available Janus Kinase Inhibitor

 #18 | 2021-03-25
US20210087175A1
Chemistry; metallurgy

Crystalline Form II of Darolutamide

 #19 | 2021-02-18
US20210046096A1
Human necessities

Pharmaceutical Composition of Brigatinib

 #20 | 2020-12-10 βœ… Patent 11,040,986 granted on 2021-06-22
US20200385401A1
Chemistry; metallurgy

Crystalline forms of cabotegravir sodium

 #21 | 2020-09-17 βœ… Patent 11,512,068 granted on 2022-11-29
US20200290995A1
Chemistry; metallurgy

Process for the preparation of crystalline ridinilazole using acid addition salts

 #22 | 2020-08-20 βœ… Patent 11,192,860 granted on 2021-12-07
US20200262792A1
Chemistry; metallurgy

Co-crystal of an orally available HIF prolyl hydroxylase inhibitor

 #23 | 2020-06-25 βœ… Patent 10,975,029 granted on 2021-04-13
US20200199070A1
Chemistry; metallurgy

Crystalline eravacycline bis-hydrochloride

 #24 | 2020-06-11
US20200179288A1
Human necessities

Omeprazole Formulations

 #25 | 2020-04-02 βœ… Patent 10,961,235 granted on 2021-03-30
US20200102297A1
Chemistry; metallurgy

Crystalline form of masitinib

 #26 | 2020-02-27 βœ… Patent 10,954,235 granted on 2021-03-23
US20200062750A1
Chemistry; metallurgy

Crystalline forms of valbenazine salts

 #27 | 2020-01-23 βœ… Patent 10,966,979 granted on 2021-04-06
US20200022980A1
Human necessities

Amorphous solid dispersion of an orally available gonadotropin-releasing hormone receptor antagonist

 #28 | 2019-12-26 βœ… Patent 11,052,071 granted on 2021-07-06
US20190388404A1
Human necessities

Oral dosage form comprising rifaximin in form beta

 #29 | 2019-12-19
US20190381085A1
Human necessities

Solid Composition Comprising Amorphous Sofosbuvir

 #30 | 2019-11-28 βœ… Patent 10,919,893 granted on 2021-02-16
US20190359612A1
Chemistry; metallurgy

Process for the preparation of crystalline form C of avibactam sodium

 #31 | 2019-10-17 βœ… Patent 10,703,750 granted on 2020-07-07
US20190315744A1
Chemistry; metallurgy

Crystalline valbenazine free base

 #32 | 2019-06-20
US20190185507A1
Chemistry; metallurgy

Sofosbuvir Derivatives for the Treatment of Hepatitis C

 #33 | 2019-06-20 βœ… Patent 11,124,513 granted on 2021-09-21
US20190185473A1
Chemistry; metallurgy

Avibactam free acid

 #34 | 2019-06-13
US20190175543A1
Human necessities

Formulations Containing Amorphous Dapagliflozin

 #35 | 2019-06-06
US20190167706A1
Human necessities

Solid Pharmaceutical Composition Comprising Amorphous Sofosbuvir

 #36 | 2019-03-14
US20190077842A1
Chemistry; metallurgy

Method For Producing A Recombinant Protein With Reduced Impurities

 #37 | 2019-03-07 βœ… Patent 10,947,287 granted on 2021-03-16
US20190071481A1
Chemistry; metallurgy

DNA coding sequence for human G-CSF

 #38 | 2019-02-14 βœ… Patent 10,661,264 granted on 2020-05-26
US20190046969A1
Performing operations; transporting

Microparticles for cell disruption and/or biomolecule recovery

 #39 | 2019-02-07 βœ… Patent 10,775,384 granted on 2020-09-15
US20190041392A1
Physics

Sensitive detection of protein heterogeneity by use of enzyme cascades

 #40 | 2019-01-31 βœ… Patent 10,702,477 granted on 2020-07-07
US20190029962A1
Human necessities

Afatinib-containing formulation

 #41 | 2019-01-10 βœ… Patent 10,842,782 granted on 2020-11-24
US20190008838A1
Human necessities

Storage stable composition comprising rifaximin alpha

 #42 | 2018-11-29 βœ… Patent 10,532,058 granted on 2020-01-14
US20180338981A1
Human necessities

Process for preparing ceftolozane from 7-aminocephalosporanic acid (7-ACA)

 #43 | 2018-10-25 βœ… Patent 10,351,533 granted on 2019-07-16
US20180305319A1
Chemistry; metallurgy

Process for the preparation of carbamoylamino pyrazole derivatives

 #44 | 2018-10-18 βœ… Patent 10,160,779 granted on 2018-12-25
US20180298045A1
Chemistry; metallurgy

Synthesis of phosphoramidates

 #45 | 2018-10-04
US20180282336A1
Chemistry; metallurgy

Active Acrylamides

 #46 | 2018-09-27
US20180271890A1
Human necessities

Solid Pharmaceutical Composition Comprising Amorphous Sofosbuvir

 #47 | 2018-09-13 βœ… Patent 11,446,381 granted on 2022-09-20
US20180256722A1
Human necessities

Stable aqueous formulation for growth hormone

 #48 | 2018-08-23
US20180237378A1
Chemistry; metallurgy

Asymmetric Bisamidation of Malonic Ester Derivatives

 #49 | 2018-07-12 βœ… Patent 10,265,326 granted on 2019-04-23
US20180193351A1
Human necessities

Form C of avibactam sodium

 #50 | 2018-06-21 βœ… Patent 10,576,065 granted on 2020-03-03
US20180169076A1
Human necessities

Pharmaceutical composition containing rifaximin alpha and delta

 #51 | 2018-06-14
US20180162896A1
Chemistry; metallurgy

Synthesis of Phosphoramidates

 #52 | 2018-06-07
US20180153879A1
Human necessities

Solid Dispersion Comprising ΞΌ-Opioid Antagonists

 #53 | 2018-04-26 βœ… Patent 10,053,427 granted on 2018-08-21
US20180111903A1
Chemistry; metallurgy

Crystalline forms of cabozantinib phosphate and cabozantinib hydrochloride

 #54 | 2018-04-26 βœ… Patent 10,206,916 granted on 2019-02-19
US20180110769A1
Human necessities

Cabozantinib salts and their use as anti-cancer agents

 #55 | 2018-04-05 βœ… Patent 10,844,103 granted on 2020-11-24
US20180094036A1
Chemistry; metallurgy

Method for the purification of G-CSF

 #56 | 2018-03-22 βœ… Patent 11,203,620 granted on 2021-12-21
US20180079788A1
Chemistry; metallurgy

Constitutive yeast LLP promotor-based expression systems

 #57 | 2018-02-08 βœ… Patent 10,159,661 granted on 2018-12-25
US20180036291A1
Human necessities

Penicillin retard composition for intramuscular injection

 #58 | 2018-01-25
US20180023067A1
Chemistry; metallurgy

Method For Producing A Recombinant Protein Of Interest

 #59 | 2018-01-11
US20180008624A1
Human necessities

Pharmaceutical Compositions Comprising Ledipasvir And Sofosbuvir

 #60 | 2018-01-11 βœ… Patent 11,266,347 granted on 2022-03-08
US20180008192A1
Human necessities

Apparatus and method for producing a flow profile

 #61 | 2017-12-28
US20170369475A1
Chemistry; metallurgy

Flibanserin Hydrate

 #62 | 2017-11-30 βœ… Patent 10,711,276 granted on 2020-07-14
US20170342422A1
Chemistry; metallurgy

Sequence variants

 #63 | 2017-11-16
US20170327504A1
Chemistry; metallurgy

Synthesis of Substituted 1H-Pyrazolo[3,4-D]Pyrimidines

 #64 | 2017-11-16
US20170326153A1
Human necessities

Pharmaceutical Composition Consisting of Ceftaroline Fosamil Acetic Acid Solvate Particles Arginine Particles, Both Having A Specific Particle Size Distribution

 #65 | 2017-11-02
US20170313735A1
Chemistry; metallurgy

Improved Fluorination Process

 #66 | 2017-10-19
US20170296570A1
Human necessities

High Drug Load Tablets Comprising Sofosbuvir

 #67 | 2017-09-14
US20170258761A1
Human necessities

Pharmaceutical Compositions Comprising Canagliflozin

 #68 | 2017-09-07 βœ… Patent 10,752,930 granted on 2020-08-25
US20170253900A1
Chemistry; metallurgy

Method for producing a recombinant protein on a manufacturing scale

 #69 | 2017-08-17
US20170233330A1
Chemistry; metallurgy

Process for the preparation of 3-[(1R,2R)-3-(Dimethylamino)-1-ethyl-2-methylpropyl]-phenol

 #70 | 2017-08-17
US20170231969A1
Human necessities

Pharmaceutical Compositions of Edoxaban

 #71 | 2017-08-03
US20170218006A1
Chemistry; metallurgy

Synthesis of Phosphoramidates

 #72 | 2017-08-03 βœ… Patent 10,030,010 granted on 2018-07-24
US20170217947A1
Chemistry; metallurgy

Route of synthesis for the preparation of suvorexant

 #73 | 2017-08-03
US20170216211A1
Human necessities

Aqueous Granulation Process For Amorphous Poorly Water Soluble Drugs

 #74 | 2017-06-15
US20170166570A1
Chemistry; metallurgy

PREPARATION OF ERTAPENEM INTERMEDIATES

 #75 | 2017-04-13 βœ… Patent 10,493,089 granted on 2019-12-03
US20170100422A1
Human necessities

Solid composition comprising amorphous sofosbuvir

 #76 | 2017-03-09 βœ… Patent 10,301,274 granted on 2019-05-28
US20170066735A1
Chemistry; metallurgy

Crystalline derivatives of (S)-1-((2R,3R,4S,5S)-5-allyl-3-methoxy-4-(tosylmethyl)tetrahydrofuran-2-YL)-3-aminopropan-2-ol

 #77 | 2017-02-02 βœ… Patent 10,206,880 granted on 2019-02-19
US20170027873A1
Human necessities

Solid dispersion comprising an orexin receptor antagonist

 #78 | 2016-12-01 βœ… Patent 10,127,839 granted on 2018-11-13
US20160351079A1
Physics

Apparatus for simulating the function of human stomach and/or human intestine

 #79 | 2016-12-01
US20160346267A1
Human necessities

Pharmaceutical Composition Comprising Apixaban

 #80 | 2016-11-24
US20160340384A1
Chemistry; metallurgy

METHOD FOR REFOLDING RECOMBINANTLY PRODUCED POLYPEPTIDES

 #81 | 2016-10-13 βœ… Patent 9,725,454 granted on 2017-08-08
US20160297821A1
Chemistry; metallurgy

Crystalline forms of ponatinib hydrochloride

 #82 | 2016-09-08
US20160256433A1
Human necessities

Formulations Containing Amorphous Dapagliflozin

 #83 | 2016-07-14 βœ… Patent 10,076,749 granted on 2018-09-18
US20160200760A1
Chemistry; metallurgy

Microparticles for cell disruption and/or biomolecule recovery

 #84 | 2016-07-14 βœ… Patent 9,534,004 granted on 2017-01-03
US20160200750A1
Chemistry; metallurgy

Crystalline forms of ceftaroline fosamil

 #85 | 2016-07-07 βœ… Patent 10,537,887 granted on 2020-01-21
US20160193598A1
Performing operations; transporting

Adsorbent composition and use thereof

 #86 | 2016-06-23 βœ… Patent 9,938,239 granted on 2018-04-10
US20160176818A1
Chemistry; metallurgy

Method for preparing silodosin

 #87 | 2016-06-16 βœ… Patent 9,670,188 granted on 2017-06-06
US20160168133A1
Chemistry; metallurgy

Process for the preparation of crystalline form IV of posaconazole

 #88 | 2016-06-02 βœ… Patent 9,566,337 granted on 2017-02-14
US20160151501A1
Human necessities

Powder mixtures for antibiotic dry syrup formulations

 #89 | 2016-05-19 βœ… Patent 9,850,254 granted on 2017-12-26
US20160137661A1
Chemistry; metallurgy

Synthetic process for preparation of macrocyclic C1-keto analogs of Halichondrin B and intermediates useful therein including intermediates containing-SO-(p-tolyl) groups

 #90 | 2016-03-17 βœ… Patent 9,730,932 granted on 2017-08-15
US20160074398A1
Human necessities

Pharmaceutical composition containing crystalline macitentan

 #91 | 2016-02-18 βœ… Patent 9,481,698 granted on 2016-11-01
US20160046655A1
Chemistry; metallurgy

Process for preparing ceftaroline fosamil

 #92 | 2016-01-21 βœ… Patent 9,598,718 granted on 2017-03-21
US20160017403A1
Chemistry; metallurgy

Quantification of misfolded TNFR2:Fc

 #93 | 2016-01-14 βœ… Patent 9,382,278 granted on 2016-07-05
US20160009745A1
Chemistry; metallurgy

Process for preparing ceftaroline fosamil

 #94 | 2015-11-10 βœ… Patent 9,182,410 granted on 2015-11-10
US14516992
Physics

Quantification of misfolded TNFR2:Fc

 #95 | 2015-10-01 βœ… Patent 9,546,171 granted on 2017-01-17
US20150274732A1
Chemistry; metallurgy

Preparation of ertapenem intermediates

 #96 | 2015-09-24 βœ… Patent 9,499,504 granted on 2016-11-22
US20150266841A1
Chemistry; metallurgy

Crystalline form of vortioxetine hydrobromide

 #97 | 2015-09-03 βœ… Patent 9,254,261 granted on 2016-02-09
US20150245995A1
Human necessities

Stable quick dissolving dosage form comprising amoxicillin and clavulanic acid

 #98 | 2015-08-13 βœ… Patent 9,867,829 granted on 2018-01-16
US20150224102A1
Human necessities

Stable pharmaceutical composition containing 8-[(3R)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione or a pharmaceutically acceptable salt thereof

 #99 | 2015-07-02 βœ… Patent 9,346,853 granted on 2016-05-24
US20150183824A1
Chemistry; metallurgy

Synthesis of telaprevir and boceprevir, or pharmaceutically acceptable salts or solvates as well as intermediate products thereof including Ξ²-amino acids prepared via Mukaiyama aldol addition

 #100 | 2015-06-18 βœ… Patent 9,458,148 granted on 2016-10-04
US20150166524A1
Chemistry; metallurgy

Crystalline form of masitinib

Also check out SANDOZ AG's (Basel, Switzerland) applicant profile with 65 patent applications submitted.

AssigneeID:

3666 ⎘